Ładuje się......
Efficacy of Switching From Teriparatide to Bisphosphonate or Denosumab: A Prospective, Randomized, Open‐Label Trial
There is no consensus on an optimal treatment after daily teriparatide (TPTD). We performed a prospective, randomized, open‐label, 12‐month trial to investigate the efficacy of follow‐up treatment after daily TPTD treatment for Japanese patients. Three‐hundred patients were enrolled in this study. P...
Zapisane w:
| Wydane w: | JBMR Plus |
|---|---|
| Główni autorzy: | , , , , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
John Wiley and Sons Inc.
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6139701/ https://ncbi.nlm.nih.gov/pubmed/30283910 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbm4.10054 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|